Literature DB >> 10072416

The increasing incidence of hepatocellular carcinoma.

N Ince, J R Wands.   

Abstract

Entities:  

Mesh:

Year:  1999        PMID: 10072416     DOI: 10.1056/NEJM199903113401009

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  36 in total

1.  The phosphoinositide 3-kinase regulatory subunit p85alpha can exert tumor suppressor properties through negative regulation of growth factor signaling.

Authors:  Cullen M Taniguchi; Jonathon Winnay; Tatsuya Kondo; Roderick T Bronson; Alexander R Guimaraes; José O Alemán; Ji Luo; Gregory Stephanopoulos; Ralph Weissleder; Lewis C Cantley; C Ronald Kahn
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

2.  Localized Hepatocellular Carcinoma.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-12

3.  Computed tomography-guided transarterial chemoembolization as the initial therapy for hepatocellular carcinoma: experience of 75 cases in a single institute.

Authors:  Yoichi Okada; Hiroyasu Ina; Kazunori Kubota; Yoshiro Himeno; Toshihiko Wakita; Isamu Ohashi; Naoya Gomi; Tetsuo Yoshida; Sunao Mae; Tetsuya Irie
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

4.  Growth rate of primary single hepatocellular carcinoma: determining optimal screening interval with contrast enhanced computed tomography.

Authors:  Kazunori Kubota; Hiroyasu Ina; Yoichi Okada; Tetsuya Irie
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

Review 5.  Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science.

Authors:  Shinji Tanaka; Shigeki Arii
Journal:  Int J Clin Oncol       Date:  2010-05-27       Impact factor: 3.402

6.  Molecularly targeted therapy for hepatocellular carcinoma from the basic and clinical aspects.

Authors:  Shigeki Arii
Journal:  Int J Clin Oncol       Date:  2010-05-27       Impact factor: 3.402

7.  Tumor-infiltrating lymphocytes and hepatocellular carcinoma.

Authors:  Yoshihiko Maehara
Journal:  Int J Clin Oncol       Date:  2010-11-06       Impact factor: 3.402

8.  Therapeutic results of computed-tomography-guided transcatheter arterial chemoembolization for local recurrence of hepatocellular carcinoma after initial transcatheter arterial chemoembolization: the results of 85 recurrent tumors in 35 patients.

Authors:  Mikio Tezuka; Keiji Hayashi; Yoichi Okada; Tetsuya Irie; Hiroyasu Ina
Journal:  Dig Dis Sci       Date:  2008-07-23       Impact factor: 3.199

9.  [Clinical utility of serous tumoural markers].

Authors:  A Martín Suárez; L Alonso Díaz; I Ordiz Alvarez; J Vázquez; F Vizoso Piñeiro
Journal:  Aten Primaria       Date:  2003       Impact factor: 1.137

10.  Asymptomatic advanced hepatocellular carcinoma presenting with spinal cord compression.

Authors:  Victor A Garcia; Ricardo Castillo
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.